Skip to main content
. 2024 Aug 30;19(8):e0299770. doi: 10.1371/journal.pone.0299770

Table 1. Table showing participant type and number of participants that took part in the focus groups and semi-structured interviews.

Focus Groups Number of Focus Groups Number of Participants
GP group 2 2, 6
Pharmacist group (mix of primary and secondary care pharmacists) 2 3, 5
Clinical pharmacologist group 1 3
Psychiatrist group (mix of secondary care and prison care) 1 2
Patient focus group (a) individuals with mental and physical health co-morbidity, in whom the prescribing for mental health improvement can lead to adverse physical health consequences. (Mental and physical co-morbidities FG) 1 6
Patient focus group (b) those with complex multimorbidity (four or more long-term health conditions taking ten or more drugs). (Complex multimorbidity FG) 1 4
Patient focus group (c) older people with frailty who are at high risk of adverse outcomes. (Older people with frailty FG) 1 3
Semi-structured Interviews Number of Interviews
Primary care pharmacist 1
Secondary care pharmacist 1
Policy-maker 1
Secondary care psychiatrist 1
Postgraduate GP-trainee 1